TP53 and cancer: More small molecules have been identified in the second category, including Nutlin, Rita, MI-219, and Tenovins, to activate wild type p53 in cancer cells and to kill them by either directly inhibiting the interaction between MDM2 and p53 or indirectly inducing p53 acetylation [13], [14], [15], [16].